Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Compounder Empower receives FDA warning letter over GLP-1s

The FDA has issued a warning letter to compounder Empower Pharmacy over its GLP-1 weight loss treatments. It’s the third warning the Houston-based company has received in less than two years. In the

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 22 September →